Choose Us to
4 Reasons
1. Expertise and Experience
R&D/Innovation Strength
Advanced technological solutions for monoclonal antibodies, recombinant proteins, vaccines, virus- and peptide-based drugs
Project Successes
Localization of biosimilar drugs in Türkiye, process development for adenovirus-based cancer and Covid-19 vaccines, and state-supported projects during the Covid-19 pandemic
GMP Certified
GMP approvals obtained for seven biotechnological and one additional pharmaceutical product
2. Flexibility and Solution-Oriented Approach
Small and Large-Scale Projects
Production capacity tailored to each client’s needs
Customer-Focused Approach
Project-specific solutions and prompt responsiveness at every stage
3. International Quality Standards
Global Compliance
Production processes aligned with European and other international markets
Quality Assurance
Meticulous quality control and audit procedures applied to all production processes
4. References
Yerlika’s expertise and reliability are evident through its accomplished projects:
Canada Collaboration
Production and formulation of dermocosmetic products for a Canadian company
Adenovirus-Based Vaccine Project
Process development, production, and formulation studies for cancer vaccines